Abiraterone is used in combination with prednisolone to treat metastatic castration-resistant prostate cancer (mCRPC) or hormone-resistant cancer who received docetaxel (chemotherapeutic drug) previously.
Disclaimer
All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
